SHANA HENRY: Open Payments
NPI 1467106302 · VILLA RICA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 29 payments from 12 companies in 2025. Trend: 2023 $547 · 2024 $1,008 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $159 |
| Alkermes, Inc. | 4 | $74 |
| Tris Pharma Inc | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: CAPLYTA, ARISTADA, Dyanavel XR, Qelbree, FANAPT, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
